Overview

Gene Regulation by Thiazolidinediones

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of rosiglitazone on the genes of the colon
Phase:
Phase 4
Details
Lead Sponsor:
James Lewis
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
2,4-thiazolidinedione
Rosiglitazone